» Articles » PMID: 34741237

Animal Models of Drug-induced Pulmonary Fibrosis: an Overview of Molecular Mechanisms and Characteristics

Overview
Publisher Springer
Specialties Cell Biology
Toxicology
Date 2021 Nov 6
PMID 34741237
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by progressive loss of pulmonary function. Drug-induced interstitial lung disease has been reported as a severe adverse effect of some drugs, such as bleomycin, amiodarone, and methotrexate. Based on good characteristics, drug-induced pulmonary fibrosis (PF) animal model has played a key role in our understanding of the molecular mechanisms of PF pathogenesis and recapitulates the specific pathology in patients and helps develop therapeutic strategies. Here, we summarize the mechanisms and characteristics of given fibrotic drug-induced animal models for PFs. Together with the key publications describing these models, this brief but detailed overview would be helpful for the pharmacological research with animal models of PFs. Potential mechanisms underlying drug induced lung toxicity.

Citing Articles

Mitochondrial transplantation via injection of exogenous mitochondria into blood reduces bleomycin-induced oxidative damages and mitochondrial dysfunction in lung tissue.

Salimi A, Shabani M, Shahsavar S, Naserian A, Khezri S, Karroubian H J Mol Histol. 2025; 56(2):104.

PMID: 40063258 DOI: 10.1007/s10735-025-10386-7.


Development of delayed pulmonary toxicities and transcriptional changes in pre-existing interstitial lung disease mice after partial thoracic irradiation.

Fu J, Liu X, Zhou Y, Zhao S, Zeng L, Pan Y Radiat Oncol. 2025; 20(1):20.

PMID: 39920834 PMC: 11806759. DOI: 10.1186/s13014-025-02596-w.


The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.


Benzo (A) pyrene exposure alters alveolar epithelial and macrophage cells diversity and induces antioxidant responses in lungs.

Chauhan P, Bhardwaj N, Rajaura S, Chandra H, Singh A, Babu R Toxicol Rep. 2024; 13:101777.

PMID: 39506978 PMC: 11539143. DOI: 10.1016/j.toxrep.2024.101777.


A novel pulmonary fibrosis NOD/SCID murine model with natural aging.

Ma Z, Qiu L, Sun J, Wu Z, Liang S, Zhao Y BMC Pulm Med. 2024; 24(1):457.

PMID: 39285370 PMC: 11406766. DOI: 10.1186/s12890-024-03268-3.


References
1.
Abidi A, Bahri S, Ben Khamsa S, Legrand A . A comparative study of intratracheal and aerosolization instillations of bleomycin inducing experimental lung fibrosis in rat. Toxicol Mech Methods. 2018; 29(2):75-85. DOI: 10.1080/15376516.2018.1512181. View

2.
Ackermann M, Kim Y, Wagner W, Schuppan D, Valenzuela C, Mentzer S . Effects of nintedanib on the microvascular architecture in a lung fibrosis model. Angiogenesis. 2017; 20(3):359-372. PMC: 7412751. DOI: 10.1007/s10456-017-9543-z. View

3.
Al-Hamdany M, Al-Hubaity A . The structural changes of the rat's lung induced by intraperitoneal injection of 5-fluorouracil. J Pak Med Assoc. 2014; 64(7):734-8. View

4.
Almudever P, Milara J, De Diego A, Serrano-Mollar A, Xaubet A, Perez-Vizcaino F . Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis. Thorax. 2013; 68(10):938-48. DOI: 10.1136/thoraxjnl-2013-203408. View

5.
Arpag H, Gul M, Aydemir Y, Atilla N, Yigitcan B, Cakir T . Protective Effects of Alpha-Lipoic Acid on Methotrexate-Induced Oxidative Lung Injury in Rats. J Invest Surg. 2017; 31(2):107-113. DOI: 10.1080/08941939.2017.1296513. View